13.300
+0,00%
2026-05-27
Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -27.7% | +4.6% | 2 / 3 | +5.1% | -3.29 pp | -7.60 pp | +6.5% | 0.00 | 18.56 | 21,0 | +5,1% | 3,5 | −27,7% | 18.56 | 27.99 | −33,7% |
| Pts | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 13.300 (close price on 2026-05-27)EPS (TTM): 716,8
Financial charts
1.Revenue & growth
VND bn21,0Q2/26
1.Revenue & growth
VND bn21,0Q2/26
2.Profit & growth
VND bn3,52Q2/26
3.Profit mix (Penman)
VND bn16,3Q2/26
4.Margins & cost structure
%32.6%Q2/26
5.Returns & cash cycle
% · days5.9%Q2/26
6.Earnings quality & cash
VND bn24,1Q2/26
7.Asset structure
VND bn212Q2/26
8.Funding & debt health
VND bn · times212Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %18,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %196Q2/26
Adjusted EPS growth, latest quarter
-27.7%
Average adjusted EPS growth, 3 quarters
4.6%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26